Helen Wirstiuk
About Helen Wirstiuk
Helen Wirstiuk is the Senior Sales Training Manager-Oncology at Bristol-Myers Squibb, with extensive experience in immuno-oncology, CNS rare disease, biologics, and injectables.
Title
Helen Wirstiuk holds the position of Senior Sales Training Manager-Oncology at Bristol-Myers Squibb in Lawrenceville, NJ.
Company
Helen Wirstiuk is currently employed at Bristol-Myers Squibb, where she works as a Senior Sales Training Manager-Oncology.
Previous Employers
Helen Wirstiuk has extensive experience in the pharmaceutical industry, having previously worked at Teva Pharmaceuticals, Ortho Biotech, and Janssen Pharmaceutica. At Teva Pharmaceuticals, she served in roles such as Sales Learning & Development Manager from 2016 to 2019, and as a Senior Executive Sales Representative from 2009 to 2016. Before Teva, she was with Ortho Biotech as a Senior Nephrology Product Specialist from 2004 to 2009 and with Janssen Pharmaceutica as a Professional Sales Representative from 2001 to 2004.
Education and Expertise
Helen Wirstiuk studied Business/Accounting at Temple University, where she earned a BS degree. She holds a CPA, which demonstrates her analytical and consultative skill set. Her expertise spans oncology, CNS, nephrology, and pain management. She has a strong understanding of immuno-oncology, CNS rare diseases, biologics, and injectables and is well-versed in Adult Learning Principles.
Achievements
Helen Wirstiuk has a proven record of success in sales and sales training. She is a recipient of the Encore Award for Training Excellence, has won the President Cup five times, and has earned numerous Outstanding Sales Leadership Awards.
Skills and Specializations
Helen Wirstiuk has strong facilitation and platform skills, experience in curriculum design and development, and is proficient in eLearning platforms. Her project management experience includes five years in marketing project management, along with strong vendor management skills. She also has expertise in learning and needs assessment and is proficient in collaborative partnering. Her strong business acumen and analytical skills are complemented by experience in launches into rare diseases.